|
|
Volumn 41, Issue 1, 2006, Pages 124-125
|
|
Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
AMPRENAVIR PHOSPHATE;
ATAZANAVIR;
CD4 ANTIGEN;
CHOLESTEROL;
EMTRICITABINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LAMIVUDINE;
LOPINAVIR;
PROTEINASE;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
TRIACYLGLYCEROL;
VIRUS RNA;
ZIDOVUDINE;
ANAMNESIS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DIGESTIVE SYSTEM;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG HYPERSENSITIVITY;
DRUG TOLERABILITY;
DRUG TOLERANCE;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
LABORATORY;
LACTIC ACIDOSIS;
LETTER;
LIPOATROPHY;
PRIORITY JOURNAL;
TREATMENT FAILURE;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CARBAMATES;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
HIV INFECTIONS;
HUMANS;
OLIGOPEPTIDES;
PHOSPHORIC ACID ESTERS;
PYRIDINES;
SULFONAMIDES;
TREATMENT FAILURE;
VIREMIA;
|
|
EID: 28944449206
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/01.qai.0000192003.00530.9c Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
